DeutschNewstral
Article
Mmarketwatch.com on 2018-09-14 13:05
Biotech Arvinas to offer 6.7 million shares in IPO priced at $14 to $16 each
Related news
- MBiotech Cibus to offer 6.7 million shares in IPO, priced at $14 to $16 eachmarketwatch.com
- MAxonics to offer 6.7 million shares in IPO, priced at $14 to $16 eachmarketwatch.com
- MProgenity to offer 6.7 million shares in planned IPO priced at $14 to $16 eachmarketwatch.com
- MHookipa Pharma to offer 6.7 million shares in IPO, priced at $14 to $16 eachmarketwatch.com
- MBiotech Alzheon to offer 6 million shares in planned IPO priced at $4 to $6 eachmarketwatch.com
- MBiotech Inhibrx to offer 6 million shares in planned IPO, priced at $16 to $18 eachmarketwatch.com
- MBiotech Nurix Therapeutics to offer 11 million shares in planned IPO, priced at $17 to $18 eachmarketwatch.com
- MTrevi Therapeutics to offer 6.7 million shares in planned IPO priced at $14 to $16 eachmarketwatch.com
- MZekelman Industries to offer 41.8 million shares in IPO, priced at $17 to $19 eachmarketwatch.com
- MLevi Strauss to offer 36.7 million shares in IPO priced at $14 to $16 eachmarketwatch.com
- MCloudflare to offer 35 million shares in IPO priced at $10 to $12 eachmarketwatch.com
- M10x Genomics to offer 9 million shares in planned IPO, priced at $31 to $35 eachmarketwatch.com
- MPandion Therapeutics upsizes planned IPO, to offer 7 million shares priced at $16 to $18 eachmarketwatch.com
- MEventbrite to offer 10 million shares in IPO priced at $19 to $21 eachmarketwatch.com
- MUpwork to offer 12.3 million shares in IPO, priced at $12 to $14 eachmarketwatch.com
- MBiopharma Moderna to offer 21.7 million shares in IPO, priced at $22 to $24 eachmarketwatch.com
- MCloud company Fastly to offer 11.3 million shares in IPO priced at $14 to $16 eachmarketwatch.com
- MIGM Biosciences to offer 7.8 million shares in planned IPO, priced at $15 to $17 eachmarketwatch.com
- MOutset Medical to offer 7.6 million shares in planned IPO, priced at $22 to $24 eachmarketwatch.com
- MAssetMark Financial to offer 12.5 million shares in planned IPO, priced at $19 to $21 eachmarketwatch.com